Li Zhou, Yong Ju, Zhijuan Cao, Sheng Cai, Jiayuan Su, Jianzhong Lu. DNA-Encoded Library Screening Identifies CDK2-Targeting Lead Compounds with Favorable Drug-like Properties for Anticancer Development[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2025.101498
| Citation:
|
Li Zhou, Yong Ju, Zhijuan Cao, Sheng Cai, Jiayuan Su, Jianzhong Lu. DNA-Encoded Library Screening Identifies CDK2-Targeting Lead Compounds with Favorable Drug-like Properties for Anticancer Development[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2025.101498
|
Li Zhou, Yong Ju, Zhijuan Cao, Sheng Cai, Jiayuan Su, Jianzhong Lu. DNA-Encoded Library Screening Identifies CDK2-Targeting Lead Compounds with Favorable Drug-like Properties for Anticancer Development[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2025.101498
| Citation:
|
Li Zhou, Yong Ju, Zhijuan Cao, Sheng Cai, Jiayuan Su, Jianzhong Lu. DNA-Encoded Library Screening Identifies CDK2-Targeting Lead Compounds with Favorable Drug-like Properties for Anticancer Development[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2025.101498
|
DNA-Encoded Library Screening Identifies CDK2-Targeting Lead Compounds with Favorable Drug-like Properties for Anticancer Development
-
1. School of Pharmaceutical Sciences, Fudan University. Laboratory of Smart Drug Delivery, MOE, Shanghai, 201203, China;
-
2. Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China;
-
3. WuXi APP Tech, Shanghai, 200131, China
- Received Date:
Apr. 17, 2025
- Accepted Date:
Nov. 24, 2025
- Rev Recd Date:
Nov. 24, 2025
- Available Online:
Nov. 26, 2025